Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBP vs RYOIX overlap: 15% of top holdings shared

Bottom line

How much do BBP and RYOIX overlap?

15% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 8.1% of BBP's assets and 9.8% of RYOIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

BBPRYOIX
Weight overlap (top 25)15%
Shared holdings5
Weight in shared holdings8.1%9.8%
Total positions7074
Expense ratio0.34%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings BBP and RYOIX have in common

Holding% of BBP% of RYOIXOverlap
Regeneron Pharmaceuticals REGN1.72%2.93%1.72%
Bridgebio Pharma Inc BBIO1.65%1.38%1.38%
Beone Medicines Ltd ONC1.65%2.17%1.65%
Roivant Sciences Ltd ROIV1.55%1.66%1.55%
Incyte Corp INCY1.52%1.62%1.52%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBP

  1. Crinetics Pharmaceuticals Inc — 3.34%
  2. Kiniksa Pharmaceuticals International Plc — 1.97%
  3. Verastem Inc — 1.95%
  4. Precigen Inc — 1.94%
  5. Omeros Corp — 1.87%
  6. Nuvation Bio Inc — 1.77%
  7. Protagonist Therapeutics Inc — 1.71%
  8. Acadia Pharmaceuticals Inc — 1.69%
  9. Xeris Biopharma Holdings Inc — 1.64%
  10. Halozyme Therapeutics Inc — 1.64%
  11. Liquidia Corp — 1.63%
  12. Immunocore Holdings Plc — 1.61%
  13. Ironwood Pharmaceuticals Inc — 1.60%
  14. Arrowhead Pharmaceuticals Inc — 1.56%
  15. Ligand Pharmaceuticals — 1.55%

Only in RYOIX

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Revolution Medicines Inc — 2.48%
  6. Alnylam Pharmaceuticals Inc — 2.36%
  7. Moderna Inc — 2.15%
  8. Biogen Inc — 2.13%
  9. Natera Inc — 2.12%
  10. Royalty Pharma Plc — 2.01%
  11. Illumina Inc — 1.94%
  12. Insmed Inc — 1.79%
  13. United Therapeutics Corp — 1.72%
  14. Guardant Health Inc — 1.72%
  15. Viatris Inc — 1.55%

Asset mix

Asset typeBBPRYOIX
Stocks99.8%99.6%
Cash & short-term funds0.7%0.6%
Repurchase agreements—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryBBPRYOIX
US84.6%85.8%
GB3.6%3.2%
KY3.6%0.5%
CH3.0%3.3%
IE—2.7%
BM1.6%1.7%
DK1.5%0.9%
NL—1.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do BBP and RYOIX overlap?
About 15% by weight. 5 securities appear in both funds' top 25 holdings; they make up 8.1% of BBP's assets and 9.8% of RYOIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do BBP and RYOIX have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Beone Medicines Ltd, Roivant Sciences Ltd, Incyte Corp, Bridgebio Pharma Inc.
Should I own both BBP and RYOIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, BBP or RYOIX?
RYOIX is broader, with 74 positions versus 70 for BBP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.